title: Coats' disease with macular oedema responsive to aflibercept and argon laser.
abstract: METHODS
  A 14 year-old boy with Coats' disease in his right eye, presented with a visual acuity (VA) of 0.1, micro-aneurysms, exudates, a macular oedema of 959 microns, and peripheral telangiectasias. After 12 months follow-up with 6 ranibizumab injections and 3 sessions of argon laser photocoagulation, the macular oedema remained and VA was 0.2. Following 4 aflibercept injections and another 2 laser sessions, he had a good foveal slope and a VA of 0.5, with no recurrences in the last 12 months.
  
  
  CONCLUSIONS
  Treatment with aflibercept and argon laser was effective in our patient with stage 2B Coats' disease and macular oedema unresponsive to ranibizumab.
authors.affiliation: Servicio de Oftalmología, Hospital Dr. Peset, Valencia, España. Electronic address: mariaguixeres@gmail.com.
authors.forename: M C
authors.initials: MC
authors.lastname: Guixeres Esteve
authors.affiliation: Servicio de Oftalmología, Hospital Dr. Peset, Valencia, España.
authors.forename: A O
authors.initials: AO
authors.lastname: Pardo Saiz
mesh_terms: D000293:Adolescent; D003131:Combined Modality Therapy; D006801:Humans; D054020:Lasers, Gas / Q000627:therapeutic use*; D008269:Macular Edema / Q000150:complications / Q000628:therapy*; D008297:Male; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012074:Remission Induction; D058456:Retinal Telangiectasis / Q000150:complications / Q000628:therapy*
chemical_list: D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor
keywords: Aflibercept; Argon laser; Coats’ disease; Enfermedad de Coats; Láser argón; Ranibizumab